Chlorthalidone Recall Report: What Patients Should Know

Reports circulating online describe a possible nationwide recall involving 25 mg chlorthalidone tablets manufactured by Inventia Healthcare Limited. The reported reason is failure to meet dissolution specifications, a laboratory quality test that measures how a tablet releases its active ingredient.

The reported affected batch is RISA24002, with an expiration date of April 2027. One secondary report claims that approximately 13,000 tablets were recalled. However, the available information comes from social media posts rather than a complete FDA or manufacturer recall notice. Patients should verify the details through the FDA, their pharmacy, or their prescriber before taking action.

Do not stop or change blood pressure treatment without professional advice. Abruptly interrupting medication can allow blood pressure to rise and may create additional health risks.

Reported Product Details

Detail	Reported information
Medication	Chlorthalidone tablets
Strength	25 mg
Manufacturer	Inventia Healthcare Limited
Reported quantity	13,000 tablets
Affected batch	RISA24002
Expiration date	April 2027
Reported reason	Failed dissolution specifications
Reported scope	Nationwide

These details should remain classified as reported until confirmed through an official FDA announcement, manufacturer communication, or pharmacy notice. The available summaries do not provide a complete National Drug Code, distributor name, recall classification, official recall date, or manufacturer contact information.

Social media posts identify the reported product and batch, but repeated posts do not independently establish the recall’s classification, distribution scope, or required patient action. Background reports include Source 1, Source 2, Source 3, Source 4, and Source 5.

What Is Chlorthalidone?

Chlorthalidone is a prescription thiazide-like diuretic, often called a water pill. It helps the kidneys remove sodium and water from the body, reducing fluid volume and lowering blood pressure. Healthcare professionals may also prescribe it for fluid retention associated with certain medical conditions.

The correct dose and treatment plan depend on the patient’s diagnosis, kidney function, other medications, and overall health. Chlorthalidone is not interchangeable with another blood pressure medicine without professional guidance.

What Does Dissolution Testing Measure?

Dissolution testing measures how quickly and completely a tablet releases its active ingredient into a liquid under controlled laboratory conditions. The test helps determine whether the medication is likely to release its active ingredient consistently after it is taken.

A tablet may fail dissolution testing if it releases the active ingredient:

• Too slowly
• Too quickly
• Incompletely
• In a pattern outside the approved specification

A failed dissolution result means the tested batch did not meet a required quality standard. It does not automatically mean that every tablet is dangerous, contaminated, or unable to treat the condition. It indicates that the product did not satisfy a specified manufacturing or quality requirement.

The available reports identify dissolution specifications as the concern. They do not report contamination, incorrect ingredients, foreign material, or tampering.

How a Dissolution Problem Could Affect Treatment

If a tablet does not dissolve as expected, the body may not receive the intended amount of medication at the intended rate. This could affect how consistently chlorthalidone works.

Potential concerns include:

• Blood pressure that is not controlled as expected
• Less effective removal of excess fluid
• Variation in medication exposure
• Uncertainty about the dose absorbed

These are potential quality concerns, not proof that every patient using the reported batch will experience harm. The clinical significance depends on the specific defect, test results, product formulation, and the patient’s health status.

Patients cannot determine dissolution performance by examining a tablet’s color, shape, or appearance. A tablet can look normal and still require laboratory testing.

How to Check Whether Your Medication Is Affected

1. Inspect the Container

Check the pharmacy bottle, blister pack, or original carton. Look for:

• Medication name
• Strength
• Manufacturer
• Batch or lot number
• Expiration date
• National Drug Code or product code, if listed

The reported batch is RISA24002, and the reported expiration date is April 2027. Matching the medication name or strength alone does not confirm that a product is recalled. The pharmacy may have dispensed a different batch or manufacturer’s product.

Keep the original container available. Do not transfer the tablets to an unmarked container before receiving instructions.

2. Contact the Dispensing Pharmacy

Ask the pharmacy that filled the prescription whether your medication came from batch RISA24002. Also ask:

• Whether the product matches the reported batch
• Whether an unaffected batch is available
• Whether a replacement prescription is needed
• How to return or dispose of the medication
• Whether you should continue taking the current supply while a replacement is arranged

A pharmacist can identify the product and coordinate with the prescriber without unnecessarily interrupting treatment.

3. Check Official Sources

Review the FDA Drug Recalls page and any notice issued by the manufacturer. Before relying on a recall report, confirm the:

• Official recall date
• Product name and strength
• National Drug Code
• Batch or lot number
• Expiration date
• Recall classification
• Distribution details
• Manufacturer instructions
• Return, replacement, or disposal process

What Patients Should Do

Do Not Stop Treatment Without Medical Advice

Do not abruptly stop chlorthalidone or switch to another blood pressure medication without speaking with a prescriber or pharmacist. The appropriate response depends on your blood pressure readings, other medications, kidney function, heart conditions, electrolyte levels, replacement availability, and whether your medication actually belongs to the reported batch.

Do not take extra tablets to compensate for a missed dose. Do not double the next dose unless a healthcare professional specifically instructs you to do so.

Ask About an Unaffected Supply

If your medication matches the reported batch, ask the pharmacy about an unaffected lot or an appropriate replacement. Do not substitute another medication based only on a label comparison or advice from an unrelated source.

Keep the medication in its original container until the pharmacy provides return or disposal instructions. Do not share the tablets with another person.

Follow Disposal Instructions

Pharmacies may provide specific return instructions for recalled medication. Follow those instructions rather than flushing the tablets or placing them in household waste unless official guidance recommends that method.

Monitor Blood Pressure and Symptoms

If you have a home blood pressure monitor, record the following while speaking with a healthcare professional:

• Date and time
• Blood pressure
• Heart rate
• Medication time
• Symptoms
• Any missed or delayed dose

A single elevated reading does not always indicate an emergency. Repeated abnormal readings should be discussed with a clinician, particularly if treatment has been interrupted or changed.

Contact a healthcare professional promptly for severe dizziness, fainting, new or worsening swelling, unusual weakness, significant changes in urination, dehydration symptoms, or persistent blood pressure changes.

Seek emergency care for:

• Chest pain
• Trouble breathing
• Loss of consciousness
• New confusion
• Severe headache with neurological symptoms
• Weakness or numbness on one side
• Extremely high blood pressure with concerning symptoms

The reported recall is not automatically an emergency for every patient. Severe symptoms require urgent evaluation regardless of whether the medication is from the affected batch.

Common Chlorthalidone Side Effects

General side effects associated with chlorthalidone can include:

• Increased urination
• Dizziness
• Low blood pressure
• Dehydration
• Changes in potassium or sodium
• Increased uric acid
• Weakness
• Lightheadedness when standing

These effects do not show that the reported batch caused a specific problem. Patients with kidney disease, gout, diabetes, or a history of electrolyte abnormalities may need additional monitoring. Contact a healthcare professional about persistent, severe, or unusual symptoms.

What the Available Reports Do Not Establish

The available summaries do not confirm contamination, incorrect ingredients, foreign material, tampering, or a complete official recall record. They also do not provide a recall classification, official announcement date, National Drug Code, product photographs, distribution list, manufacturer contact information, or pharmacy return instructions.

A nationwide claim may refer to distribution across the United States, while the actual recall may apply only to a specific lot, product code, or distributor. The official notice, if available, should determine the specific hazard and required action.

Frequently Asked Questions

What blood pressure medication was reportedly recalled?

The available source material identifies 25 mg chlorthalidone tablets manufactured by Inventia Healthcare Limited. The report requires confirmation through an official FDA, manufacturer, or pharmacy notice.

What batch was reportedly recalled?

The reported batch is RISA24002, with a reported expiration date of April 2027. Ask a pharmacist to confirm whether your container matches the affected batch.

What does a failed dissolution test mean?

It means the tablet did not meet laboratory specifications for releasing its active ingredient under controlled conditions. It may affect the consistency of drug release, but it does not by itself prove that every tablet will cause harm.

Should I stop taking the reported medication?

Do not stop or change treatment without speaking with a prescriber or pharmacist. Ask whether you should continue the current supply temporarily, receive an unaffected batch, or use another treatment.

What should I do with the tablets?

Contact the dispensing pharmacy for return, replacement, or disposal instructions. Keep the medication in its original container, and do not flush it unless official guidance specifically recommends that method.

Where can I verify the report?

Check the FDA Drug Recalls page, the manufacturer’s communication, and the dispensing pharmacy. An official regulatory link, recall date, product code, and classification should be added once verified.

Conclusion

Reports describe a possible nationwide recall involving 25 mg chlorthalidone tablets from Inventia Healthcare Limited after the product reportedly failed dissolution specifications. The reported batch is RISA24002, with an expiration date of April 2027.

The available information is not a complete official recall notice. Check your bottle for RISA24002, then confirm its status with the dispensing pharmacy, prescriber, manufacturer, or an official FDA notice. Do not stop, switch, return, or dispose of the medication without appropriate guidance.